KIM
TWST icon

Kestra Investment Management’s Twist Bioscience TWST Stock Holding History

Kestra Investment Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-418
Closed -$15.9K – 955
2025
Q2 		$15.9K Buy
418
+191
+84% +$6.6K ﹤0.01% 661
2025
Q1 		$8.91K Buy
+227
New +$10.2K ﹤0.01% 631

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Kestra Investment Management's TWST Position: Q3 2025 in Review

Kestra Investment Management sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 418 shares — an estimated $15.9K sold.

Kestra Investment Management first reported a position in TWST in Q1 2025 and held it in 2 quarters. The position peaked at $15.9K in Q2 2025. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

  • Kestra Investment Management reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
  • Kestra Investment Management sold 418 Twist Bioscience shares in Q3 2025, an estimated $15.9K.
  • Kestra Investment Management first reported a position in Twist Bioscience in Q1 2025 and held it in 2 quarters.
  • Kestra Investment Management's Twist Bioscience position peaked at $15.9K in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on Kestra Investment Management's 13F filing for Q3 2025, filed 17 Nov 2025.